Dashboard
Manage Tickers

DTIL


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

precision-biosciences-secures-13m-from-imugene-convertible-note-maturity-as-part-of-azer-cel-deal
Precision BioSciences Secures $13M From Im...
09/03/2024 11:27:37

-- Payment includes $9.75 million cash and $3.25 million in Imugene Limited ordinary shares-- --The addition of this cash furt...

hc-wainwright--co-reiterates-buy-on-precision-biosciences-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
08/22/2024 16:19:27

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60...

precision-biosciences-says-partner-tg-therapeutics-gets-us-fda-clearance-for-investigational-new-drug-ind-application-to-investigate-azercabtagene-zapreleucel-azer-cel-in-human-clinical-trials-for-multiple-sclerosis
Precision Biosciences Says Partner TG Ther...
08/09/2024 11:08:02

precision-biosciences-had-approximately-1236m-in-cash-and-cash-equivalents-as-of-june-30-with-cash-runway-expected-into-the-second-half-of-2026
Precision BioSciences Had Approximately $1...
08/01/2024 12:03:40

precision-biosciences-q2-2024-gaap-eps-467-beats-138-estimate-sales-49898m-may-not-be-comparable-to-8856m-estimate
Precision BioSciences Q2 2024 GAAP EPS $4....
08/01/2024 12:02:05

precision-biosciences-showcases-arcus-platform-at-mitochondrial-medicine-2024
Precision BioSciences Showcases ARCUS Plat...
06/27/2024 11:07:57

Precision BioSciences, Inc. (NASDAQ:DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to ...

precision-biosciences-to-present-preclinical-data-on-hepatitis-b-treatment-at-easl-congress
Precision BioSciences to Present Preclinic...
06/05/2024 11:07:19

Precision BioSciences, Inc. (NASDAQ:DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to ...

hc-wainwright--co-reiterates-buy-on-precision-biosciences-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
05/30/2024 11:09:37

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60...

deep-dive-into-precision-biosciences-stock-analyst-perspectives-4-ratings
Deep Dive Into Precision BioSciences Stock...
05/16/2024 18:00:24

hc-wainwright--co-reiterates-buy-on-precision-biosciences-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
05/16/2024 17:36:26

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60...

precision-biosciences-q1-eps-170-beats-191-estimate-sales-1758m-beat-602m-estimate
Precision BioSciences Q1 EPS $1.70 Beats $...
05/13/2024 11:03:30

Precision BioSciences (NASDAQ:DTIL) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of...

precision-biosciences-announces-common-stock-purchase-by-members-of-management-including-ceo--for-300000-in-private-placement
Precision BioSciences Announces Common Sto...
05/08/2024 12:18:51

precision-biosciences-announces-receipt-of-fda-fast-track-designation-for-ecur-506-iecures-program-for-the-treatment-of-neonatal-onset-ornithine-transcarbamylase-deficiency
Precision BioSciences Announces Receipt Of...
05/07/2024 12:37:53

Precision BioSciences, Inc. (NASDAQ:DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to ...

precision-biosciences-disclosed-late-breaking-poster-presentation-at-the-european-association-for-study-of-the-liver-congress-2024
Precision Biosciences Disclosed Late-break...
05/01/2024 11:27:47

guggenheim-initiates-coverage-on-precision-biosciences-with-buy-rating-announces-price-target-of-19
Guggenheim Initiates Coverage On Precision...
04/30/2024 11:41:44

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Precision BioSciences (NASDAQ:DTIL) with a Buy rating and anno...

hc-wainwright--co-reiterates-buy-on-precision-biosciences-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Prec...
04/17/2024 17:26:55

HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $60...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/17/2024 12:08:12

precision-biosciences-announces-return-of-programs-and-conclusion-of-collaboration-with-prevail-therapeutics
Precision BioSciences Announces Return Of ...
04/16/2024 20:17:19

- Productive collaboration advanced three programs and demonstrated proof of concept of ARCUS for gene excision and gene insert...

iecure-announces-fda-clearance-of-ind-application-for-ecur-506-to-initiate-otc-hope-trial-for-treatment-of-neonatal-onset-ornithine-transcarbamylase-deficiency-in-the-us-note-iecure-has-licensed-the-arcus-nuclease-for-ecur-506-from-precision-biosciences
iECURE Announces FDA Clearance Of IND Appl...
04/04/2024 15:02:53

Clinical trial sites in the United States, United Kingdom, and Australia will evaluate ECUR-506, an investigational gene editin...

hc-wainwright--co-maintains-buy-on-precision-biosciences-adjusts-price-target-to-60
HC Wainwright & Co. Maintains Buy on Preci...
03/28/2024 14:56:08

HC Wainwright & Co. analyst Patrick Trucchio maintains Precision BioSciences (NASDAQ:DTIL) with a Buy, adjusts target to...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION